ArticleInternational cancer conference journal2026
A giant testicular tumor requiring skin valvuloplasty.
Article in International cancer conference journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant testicular tumors, typically defined as those with volumes exceeding ten times the normal testicular volume, are extremely rare in developed countries. However, a relatively high number of such cases have been reported in Japan. Social stigma and lack of awareness often contribute to delayed medical consultation, resulting in advanced disease requiring complex surgical interventions. Despite its aggressive presentation, testicular cancer is curable when diagnosed early, highlighting the importance of public education and awareness. A 45-year-old man presented with hemorrhagic shock due to bleeding from massively enlarged left scrotum. He first noticed painless scrotal swelling 3 years earlier, which rapidly progressed over the previous 6 months. Imaging revealed a 34-cm heterogeneous testicular mass with bilateral inguinal lymphadenopathy. Tumor marker levels were significantly elevated (alpha-fetoprotein: 689 ng/mL, lactate dehydrogenase: 6,566 IU/L). Emergency radical orchiectomy and bilateral inguinal lymph node dissection were performed. Due to extensive skin necrosis, vacuum-assisted closure therapy was initiated, followed by delayed skin valvuloplasty. Histopathological analysis confirmed nonseminomatous germ cell tumor (Stage IIIA), and adjuvant vincristine, ifosfamide, and cisplatin chemotherapy was administered. The patient remains recurrence-free 2 years postoperatively. Although rare, giant testicular tumors require prompt diagnosis and multidisciplinary management. Early detection is essential for preventing life-threatening complications and enabling curative treatment. Public awareness of testicular self-examination and high curability of testicular cancer can significantly reduce delays in seeking medical attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.